SGMO vs UBER · rev $57.8M vs P/E 18, rev $52.02B
Sangamo Therapeutics Inc (SGMO) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
SGMO currently screens at market cap $74.6M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the SGMO and UBER stock pages for the full models.
Not investment advice.